FDA decisions on new drug applications and the market value of pharmaceutical firms
Year of publication: |
1998
|
---|---|
Authors: | Torabzadeh, Khalil M. |
Other Persons: | Woodruff, Criss G. (contributor) ; Sen, Nilanjan (contributor) |
Published in: |
American business review. - West Haven, Conn., ISSN 0743-2348, ZDB-ID 1115252-7. - Vol. 16.1998, 2, p. 42-50
|
Subject: | Pharmaindustrie | Pharmaceutical industry | Börsenkurs | Share price | Ankündigungseffekt | Announcement effect | USA | United States | Arzneimittelrecht | Pharmaceutical law | 1981-1992 |
-
Market response to FDA announcements
Sarkar, Salil K., (2006)
-
Miller, Kathleen L., (2018)
-
Pharmaceutical Lottery Stocks : Investors’ Reaction to FDA Announcements
Kliger, Doron, (2021)
- More ...
-
FDA decisions on new drug applications and the market value of pharmaceutical firms
Torabzadeh, Khalil M., (1998)
-
Ownership structure and returns to defensive stock repurchase
Woodruff, Criss G., (1995)
-
Torabzadeh, Khalil M., (2000)
- More ...